Article
· book: the scaling curve: dario amodei, anthropic, and the race to build and survive superintelligence
· technology
The Scaling Curve: Dario Amodei, Anthropic, and the Race to Build and Survive Superintelligence — Chapter Thirteen
- 1. Anthropic achieved unprecedented revenue growth, soaring from zero to over $100 million in its first commercial year and reaching $14 billion in annualized run rate by early 2026.
- 2. Anthropic's competitive strategy against trillion-dollar rivals relies on talent density and capital efficiency rather than raw scale.
- 3. Anthropic strategically focused on the enterprise market, identifying it as having the "real value" and being neglected due to the consumer AI "death match."
- 4. Dario advised the pharmaceutical industry to ambitiously prepare for AI doing entire processes end-to-end, exemplified by the Eli Lilly partnership.
- 5. Anthropic resisted Meta's aggressive talent poaching attempts by upholding its compensation principles and refusing bidding wars.
- 6. Dario Amodei publicly defended his "race to the top" vision for AI safety against accusations from Nvidia CEO Jensen Huang of using regulation for competitive advantage.
- 7. Dario Amodei viewed chip export controls as crucial for democracies to maintain their AI lead over autocracies, considering it a national security policy question.
- 8. Anthropic deliberately managed its organizational growth, slowing hiring around 1,000 employees to maintain talent density and purpose alignment.
- 9. Daniela Amodei, Dario's sister, played an essential, underappreciated role running Anthropic's day-to-day operations and managing hypergrowth.
- 10. Dario Amodei estimated AI's total addressable market could be $5 trillion annually, representing 10% of the global labor economy.